Financial Performance - Fourth quarter net product sales reached 29.6million,anincreasefrom28.7 million in the previous quarter[6] - Full year net product sales totaled 120.8million,withRolvedonsalesexceeding60.0 million[1] - Total revenues for the three months ended December 31, 2024, were 32,182thousand,adecreaseof2.432,985 thousand for the same period in 2023[17] - Product sales, net for the year ended December 31, 2024, were 120,849thousand,down19.2149,451 thousand in 2023[17] - Net loss for the year ended December 31, 2024, was 21,581thousand,significantlyimprovedfromanetlossof331,942 thousand in 2023[21] - Basic and diluted net loss per share for the year ended December 31, 2024, was 0.23,comparedto4.67 in 2023[17] - For the three months ended December 31, 2024, the company reported a net loss of 10,476,000,translatingtoadilutedlosspershareof0.11, compared to a net loss of 57,384,000andadilutedlosspershareof0.61 for the same period in 2023[25] Cash Flow and Assets - Cash flow from operations for the fourth quarter was 11.5million,contributingtoafullyeartotalof26.4 million[1] - Assertio's cash, cash equivalents, and short-term investments totaled 100.1millionasofDecember31,2024[10]−Cashandcashequivalentsattheendoftheyearwere50,588 thousand, down from 73,441thousandattheendof2023[19]−Totalcurrentassetsincreasedto202,549 thousand as of December 31, 2024, compared to 171,062thousandin2023[19]−Thecompanyreportedanetcashprovidedbyoperatingactivitiesof26,408 thousand for the year ended December 31, 2024, down from 49,604thousandin2023[21]ExpensesandMargins−Grossmarginforthefourthquarterwas612.9 million in higher inventory write-downs[10] - Adjusted EBITDA loss for the fourth quarter was 0.5million,comparedtoadjustedEBITDAof5.3 million in the prior quarter[10] - SG&A expenses in the fourth quarter increased to 21.4million,largelyduetoa5.4 million rise in litigation contingencies[10] - Research and development expenses for the three months ended December 31, 2024, were 1,286thousand,anincreasefrom1,024 thousand in the same period of 2023[17] - Adjusted EBITDA for the year ended December 31, 2024, was 17,143thousand,comparedto67,743 thousand in 2023[22] Liabilities and Debt - Total liabilities rose to 163,651thousandin2024,upfrom148,416 thousand in 2023[19] - The company incurred approximately 8.8millionindebt−relatedexpensesand1.1 million in direct transaction costs related to the privately negotiated exchange of 30millionprincipalamountofConvertibleSeniorNotesdue2027inQ12023[24]OtherIncomeandCharges−TotalotherincomeforthethreemonthsendedDecember31,2024,was(920,000), compared to (887,000)forthepreviousquarter[24]−Thecompanyreportedachangeinfairvalueofcontingentconsiderationof(544,000) for the three months ended December 31, 2024, and (25,538,000)forthetwelvemonthsendedDecember31,2023[33]−Thecompanyrecognizedalossof5,217,000 for impairment of intangible assets during the three months ended December 31, 2024, and a total of 279,639,000forthetwelvemonthsendedDecember31,2023[33]−RestructuringchargesforthetwelvemonthsendedDecember31,2024,amountedto720,000, while for the twelve months ended December 31, 2023, it was 5,476,000[33]−Thecompany’stotalotherincomeforthetwelvemonthsendedDecember31,2024,was2,820,000, compared to 1,203,000forthetwelvemonthsendedDecember31,2023[24]FutureGuidanceandStrategy−Thecompanyannouncedinitial2025operatingguidancefornetproductsalesbetween108.0 million and $123.0 million[7] - Assertio is actively pursuing an acquisition strategy to enhance its commercial assets and scale[4]